5-64594759-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001029875.3(RGS7BP):āc.513G>Cā(p.Glu171Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000539 in 1,613,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001029875.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGS7BP | NM_001029875.3 | c.513G>C | p.Glu171Asp | missense_variant | 4/6 | ENST00000334025.3 | NP_001025046.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGS7BP | ENST00000334025.3 | c.513G>C | p.Glu171Asp | missense_variant | 4/6 | 1 | NM_001029875.3 | ENSP00000334851 | P1 | |
RGS7BP | ENST00000505263.1 | n.273G>C | non_coding_transcript_exon_variant | 2/5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250850Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135538
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1461564Hom.: 0 Cov.: 31 AF XY: 0.0000536 AC XY: 39AN XY: 727078
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74412
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2023 | The c.513G>C (p.E171D) alteration is located in exon 4 (coding exon 4) of the RGS7BP gene. This alteration results from a G to C substitution at nucleotide position 513, causing the glutamic acid (E) at amino acid position 171 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at